chitosan has been researched along with dasatinib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Adena, SKR; Mishra, B; Upadhyay, M; Vardhan, H | 1 |
| Dinari, M; Hajhashemi, V; Mirian, M; Sadeghi, HM; Shamaeizadeh, N; Vakilzadeh, H; Varshosaz, J | 1 |
| Aalhate, M; Chatterjee, E; Gupta, U; Guru, SK; Kumar, R; Mahajan, S; Maji, I; Saren, BN; Singh, PK | 1 |
3 other study(ies) available for chitosan and dasatinib
| Article | Year |
|---|---|
Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Topics: Chemistry, Pharmaceutical; Chitosan; Dasatinib; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Gold; Metal Nanoparticles; Particle Size; Polyethylene Glycols; Research Design | 2018 |
Smart redox-sensitive micelles based on chitosan for dasatinib delivery in suppressing inflammatory diseases.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Dasatinib; Drug Carriers; Drug Delivery Systems; Inflammation; Interleukin-10; Mice; Micelles; Oxidation-Reduction | 2023 |
Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Chitosan; Dasatinib; Drug Carriers; Humans; Nanoparticles; Particle Size; Rhodamines; Triple Negative Breast Neoplasms | 2024 |